GRX

The Gabelli Healthcare & Wellness Trust [GRX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GRX Stock Summary

Top GRX Correlated Resources

GRX


Top 10 Correlated ETFs

GRX


Top 10 Correlated Stocks

GRX


In the News

07:23 04 Mar 2024 GRX

GRX: There Are Better Alternatives In The Healthcare CEF Sector

The Gabelli Healthcare & WellnessRx Trust is an underperforming equity closed-end fund (CEF) focused on healthcare stocks. GRX has a -19% discount to net asset value, but has traded at very substantial discounts for the past five years. The fund employs a 27% leverage ratio, which has hampered its performance in 2023.

01:04 04 Mar 2024 GRX

GRX: Modest Healthcare Fund Trading At A Steep Discount

The Gabelli Healthcare & Wellness Rx Trust seeks to provide capital gains and income from a portfolio of healthcare and wellness-focused stocks. The fund pays an attractive 6.1% distribution yield that is well funded by its long-term 5-7% total returns. However, compared to peer funds, the GRX fund has much higher expenses, lower total returns, and higher portfolio volatility. I would personally seek healthcare exposure elsewhere.

06:19 04 Mar 2024 GRX

The Month In Closed-End Funds: April 2023

For the first month in three, equity CEFs (+0.67% on a NAV basis) on average witnessed plus-side performance. While their fixed-income CEF cohorts (+0.56%) posted gains for the second consecutive month.

04:40 04 Mar 2024 GRX

GRX: High-Yielding CEF Available At Discount, Suits Income-Seeking Investors

The Gabelli Healthcare & Wellness Rx Trust generates above-average yield and is available at a huge discount. However, its annual average total return over the past five years is not that high. Aging demographics and adoption of new medical products and services has started delivering long-term growth for healthcare firms for quite some time.

11:19 04 Mar 2024 GRX

Weekly Closed-End Fund Roundup: VFL Tender Results (December 18, 2022)

2 out of 23 CEF sectors were positive on price and 2 out of 23 sectors were positive on NAV last week. VFL offers tender results.

02:31 04 Mar 2024 GRX

GRX: Lagging Peers, But Discount Is Attractive

If you compare GRX to other healthcare peers, it has underperformed. However, GRX isn't focused solely on healthcare, so its portfolio has a bit more flexibility.

04:42 04 Mar 2024 GRX

GRX: Steady Yield And Returns, Portfolio Looks Impressive After Restructuring

Between 2017 and 2021, GRX generated a yield of 5.2 percent and total return of 12 percent. It recorded positive returns in 8 out of the past 10 years. GRX's major investments generated mixed returns over the past 5 years. But the poor performing stocks have been replaced by well-performing ones.

05:31 04 Mar 2024 GRX

GRX: Not Among The Best Closed-End Healthcare-Based Funds

GRX's total return has been negative, and yield has been quite average over the short term. GRX failed to record double digit average total return over the medium and long term.

06:21 04 Mar 2024 GRX

GRX: Replicates The Market, But Fails To Beat

GRX's return has replicated the S&P 500 index, but has always performed less than the index.

12:20 04 Mar 2024 GRX

The Month In Closed-End Funds: December 2021

The Month In Closed-End Funds: December 2021

GRX Financial details

Company Rating
Buy
Market Cap
170.86M
Income
-
Revenue
-
Book val./share
12.03
Cash/share
0
Dividend
0.6
Dividend %
6.24%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-3.48
Forward P/E
-
PEG
-
P/S
-3.53
P/B
0.81
P/C
-
P/FCF
2.84
Quick Ratio
1.89
Current Ratio
1.89
Debt / Equity
0.32
LT Debt / Equity
0.32
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-211.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
87.22%
Revenue last 5Y
98.11%
Revenue Q/Q
-65.72%
EPS Q/Q
-775.99%
-
-
-
-
SMA20
4.75%
SMA50
9.01%
SMA100
16.98%
Inst Own
20.76%
Inst Trans
0.9%
ROA
-19%
ROE
-20%
ROC
-0.18%
Gross Margin
100%
Oper. Margin
95%
Profit Margin
102%
Payout
-35%
Shs Outstand
17.15M
Shs Float
17.1M
-
-
-
-
Target Price
-
52W Range
7.73-10.4
52W High
-0.35%
52W Low
+42.36%
RSI
63.28
Rel Volume
4.06
Avg Volume
42.79K
Volume
173.91K
Perf Week
0.86%
Perf Month
5.45%
Perf Quarter
7.38%
Perf Half Y
4.24%
-
-
-
-
Beta
-
-
-
Volatility
0.06%, 0.2%
Prev Close
1.17%
Price
9.965
Change
1.17%

GRX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
-0.083.151.62.52-2.72
Net income per share
-0.123.121.552.48-2.76
Operating cash flow per share
002.89-1.13.38
Free cash flow per share
002.89-1.13.38
Cash per share
00000
Book value per share
14.5417.9415.4915.3211.91
Tangible book value per share
14.5417.9818.0915.3211.91
Share holders equity per share
14.5417.9415.4915.3211.91
Interest debt per share
002.560.122.51
Market cap
172.77M196.33M186.85M233.86M176.71M
Enterprise value
172.76M196.33M226.84M233.93M216.66M
P/E ratio
-75.83.697.735.47-3.72
Price to sales ratio
-112.853.657.475.38-3.78
POCF ratio
004.13-12.353.04
PFCF ratio
004.13-12.353.04
P/B Ratio
0.640.640.770.890.86
PTB ratio
0.640.640.770.890.86
EV to sales
-112.853.659.075.38-4.64
Enterprise value over EBITDA
-75.813.699.385.47-4.89
EV to operating cash flow
005.01-12.353.73
EV to free cash flow
005.01-12.353.73
Earnings yield
-0.010.270.130.18-0.27
Free cash flow yield
000.24-0.080.33
Debt to equity
000.1700.2
Debt to assets
000.1400.16
Net debt to EBITDA
001.650-0.9
Current ratio
1.90.661.40.081.89
Interest coverage
-19.48K0418.5222.06-13.93
Income quality
002.1-0.44-1.22
Dividend Yield
000.060.070.09
Payout ratio
000.430.39-0.35
Sales general and administrative to revenue
-0.490.010.030.02-0.02
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
6.3235.4823.2129.2327.19
ROIC
-0.010.170.090.16-0.18
Return on tangible assets
-0.010.170.080.12-0.19
Graham Net
-0.02-0.020.01-5.02-2.27
Working capital
191.23K-191.91K1.48M-5.75M3.15M
Tangible asset value
271.65M306.46M282.85M263.95M204.65M
Net current asset value
-285.03K-191.91K1.48M-86.41M-37.37M
Invested capital
000.1700.2
Average receivables
2.62M387.96K2.74M2.79M3.55M
Average payables
402.31K391.43K2.11M4.94M4.88M
Average inventory
00000
Days sales outstanding
-94.642.5774.583.99-51.78
Days payables outstanding
063.31432.87656.62377.35
Days of inventory on hand
00000
Receivables turnover
-3.86141.864.8991.37-7.05
Payables turnover
05.770.840.560.97
Inventory turnover
00000
ROE
-0.010.170.10.16-0.23
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.470.17
Net income per share
000-0.040.29
Operating cash flow per share
0000.110.04
Free cash flow per share
0000.110.04
Cash per share
00000
Book value per share
00012.0112.03
Tangible book value per share
00012.0115.9
Share holders equity per share
00012.0112.03
Interest debt per share
0002.443.92
Market cap
000175.15M166.13M
Enterprise value
92.21K68.5K-10.39K215.1M230.05M
P/E ratio
000-59.888.66
Price to sales ratio
00021.6960.02
POCF ratio
00096.27248.52
PFCF ratio
00096.27248.52
P/B Ratio
0000.860.83
PTB ratio
0000.860.83
EV to sales
00026.6483.11
Enterprise value over EBITDA
000255.4137.3
EV to operating cash flow
000118.23344.13
EV to free cash flow
000118.23344.13
Earnings yield
00000.03
Free cash flow yield
0000.010
Debt to equity
0000.20.32
Debt to assets
0000.160.24
Net debt to EBITDA
00047.4410.36
Current ratio
5.10.0811.651.8934.61
Interest coverage
0000.534.5
Income quality
000-2.490.14
Dividend Yield
0000.060.03
Payout ratio
000-15.491.05
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0003.418.82
ROIC
00000.02
Return on tangible assets
00000.02
Graham Net
000-2.290.06
Working capital
1.1M-5.75M473.5K3.15M1.33M
Tangible asset value
261.67M263.95M211.06M204.65M265.25M
Net current asset value
-39.46M-86.41M-80.01M-37.37M1.33M
Invested capital
0000.20.32
Average receivables
3.24M922.48K491.78K3.57M3.98M
Average payables
1.96M3.25M3.14M1.79M1.78M
Average inventory
00000
Days sales outstanding
00073.8743.17
Days payables outstanding
000196.632.33
Days of inventory on hand
00000
Receivables turnover
0001.222.08
Payables turnover
0000.4638.66
Inventory turnover
00000
ROE
00000.02
Capex per share
00000

GRX Frequently Asked Questions

What is The Gabelli Healthcare & Wellness Trust stock symbol ?

The Gabelli Healthcare & Wellness Trust is a US stock , located in Rye of Ny and trading under the symbol GRX

What is The Gabelli Healthcare & Wellness Trust stock quote today ?

The Gabelli Healthcare & Wellness Trust stock price is $9.965 today.

Is The Gabelli Healthcare & Wellness Trust stock public?

Yes, The Gabelli Healthcare & Wellness Trust is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap